ACCOUNTS - Final Accounts


Caseware UK (AP4) 2019.0.227 2019.0.227 2019-06-302019-06-301313true2018-07-01falsePharmaceutical ServicestrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 01933847 2018-07-01 2019-06-30 01933847 2017-07-01 2018-06-30 01933847 2019-06-30 01933847 2018-06-30 01933847 c:Director9 2018-07-01 2019-06-30 01933847 d:Buildings 2018-07-01 2019-06-30 01933847 d:Buildings 2019-06-30 01933847 d:Buildings 2018-06-30 01933847 d:Buildings d:OwnedOrFreeholdAssets 2018-07-01 2019-06-30 01933847 d:Buildings d:LeasedAssetsHeldAsLessee 2018-07-01 2019-06-30 01933847 d:Buildings d:LongLeaseholdAssets 2018-07-01 2019-06-30 01933847 d:PlantMachinery 2018-07-01 2019-06-30 01933847 d:MotorVehicles 2018-07-01 2019-06-30 01933847 d:FurnitureFittings 2018-07-01 2019-06-30 01933847 d:OtherPropertyPlantEquipment 2018-07-01 2019-06-30 01933847 d:OtherPropertyPlantEquipment 2019-06-30 01933847 d:OtherPropertyPlantEquipment 2018-06-30 01933847 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2018-07-01 2019-06-30 01933847 d:OtherPropertyPlantEquipment d:LeasedAssetsHeldAsLessee 2018-07-01 2019-06-30 01933847 d:OwnedOrFreeholdAssets 2018-07-01 2019-06-30 01933847 d:LeasedAssetsHeldAsLessee 2018-07-01 2019-06-30 01933847 d:CurrentFinancialInstruments 2019-06-30 01933847 d:CurrentFinancialInstruments 2018-06-30 01933847 d:Non-currentFinancialInstruments 2019-06-30 01933847 d:Non-currentFinancialInstruments 2018-06-30 01933847 d:CurrentFinancialInstruments d:WithinOneYear 2019-06-30 01933847 d:CurrentFinancialInstruments d:WithinOneYear 2018-06-30 01933847 d:Non-currentFinancialInstruments d:AfterOneYear 2019-06-30 01933847 d:Non-currentFinancialInstruments d:AfterOneYear 2018-06-30 01933847 d:ShareCapital 2019-06-30 01933847 d:ShareCapital 2018-06-30 01933847 d:RetainedEarningsAccumulatedLosses 2019-06-30 01933847 d:RetainedEarningsAccumulatedLosses 2018-06-30 01933847 c:FRS102 2018-07-01 2019-06-30 01933847 c:AuditExempt-NoAccountantsReport 2018-07-01 2019-06-30 01933847 c:FullAccounts 2018-07-01 2019-06-30 01933847 c:PrivateLimitedCompanyLtd 2018-07-01 2019-06-30 01933847 d:HirePurchaseContracts d:WithinOneYear 2019-06-30 01933847 d:HirePurchaseContracts d:WithinOneYear 2018-06-30 01933847 d:HirePurchaseContracts d:BetweenOneFiveYears 2019-06-30 01933847 d:HirePurchaseContracts d:BetweenOneFiveYears 2018-06-30 01933847 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2019-06-30 01933847 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2018-06-30 01933847 d:LeasedAssetsHeldAsLessee 2019-06-30 01933847 d:LeasedAssetsHeldAsLessee 2018-06-30 iso4217:GBP xbrli:pure

Registered number: 01933847










VICTORIA PHARMACY LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 JUNE 2019

 
VICTORIA PHARMACY LIMITED
REGISTERED NUMBER: 01933847

BALANCE SHEET
AS AT 30 JUNE 2019

2019
2018
Note
£
£

Fixed assets
  

Tangible assets
 4 
113,698
112,395

  
113,698
112,395

Current assets
  

Stocks
  
59,869
66,086

Debtors: amounts falling due after more than one year
 5 
72,600
75,900

Debtors: amounts falling due within one year
 5 
244,900
145,361

Cash at bank and in hand
 6 
6
232

  
377,375
287,579

Creditors: amounts falling due within one year
 7 
(466,500)
(352,080)

Net current liabilities
  
 
 
(89,125)
 
 
(64,501)

Total assets less current liabilities
  
24,573
47,894

Creditors: amounts falling due after more than one year
 8 
-
(247)

Provisions for liabilities
  

Deferred tax
  
(1,739)
(1,739)

Net assets
  
22,834
45,908


Capital and reserves
  

Called up share capital 
  
88
88

Profit and loss account
  
22,746
45,820

  
22,834
45,908


The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

Page 1

 
VICTORIA PHARMACY LIMITED
REGISTERED NUMBER: 01933847
    
BALANCE SHEET (CONTINUED)
AS AT 30 JUNE 2019

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




E L Griffiths
Director

Date: 1 April 2020

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
VICTORIA PHARMACY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2019

1.


General information

The company is a private company, limited by shares, incorporated in England and Wales and its registered office is:-
The Health Centre
Victoria Road
Hartlepool
TS26 8DB

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
The policies applied under the entity's previous accounting framework are not materially different to FRS 102 and have not impacted on equity or profit or loss.
The following principal accounting policies have been applied:

 
2.2

Going concern

The directors, having made due and careful enquiry, are of the opinion that the company has adequate working capital to execute its operations over the next 12 months. The directors, therefore, have made an informed judgment at the time of approving the financial statements, that there is reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. As a result, the directors have continued to adopt the going concern basis of accounting in preparing the annual financial statements.

 
2.3

Revenue

Turnover comprises revenue recognised by the company in respect of pharmacy goods and services supplied during the year, exclusive of Value Added Tax.

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
VICTORIA PHARMACY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2019

2.Accounting policies (continued)


2.4
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, as follows.

Depreciation is provided on the following basis:

Long-term leasehold land and buildings
-
20 years straight line
Computer equipment
-
3 years straight line
Motor vehicles
-
25% reducing balance
Fixtures and fittings
-
10% reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the statement of comprehensive income.

 
2.5

Financial instruments

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties and loans to related parties.


3.


Employees

The average monthly number of employees, including directors, during the year was 13 (2018 - 13).

Page 4

 
VICTORIA PHARMACY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2019

4.


Tangible fixed assets





Long-term leasehold land and buildings
Other fixed assets
Total

£
£
£



Cost


At 1 July 2018
96,238
39,673
135,911


Additions
-
11,823
11,823



At 30 June 2019

96,238
51,496
147,734



Depreciation


At 1 July 2018
5,781
17,735
23,516


Charge for the year on owned assets
4,812
4,377
9,189


Charge for the year on financed assets
-
1,331
1,331



At 30 June 2019

10,593
23,443
34,036



Net book value



At 30 June 2019
85,645
28,053
113,698



At 30 June 2018
90,457
21,938
112,395

The net book value of assets held under finance leases or hire purchase contracts, included above, are as follows:


2019
2018
£
£



Motor vehicles
3,994
5,235

3,994
5,235

Page 5

 
VICTORIA PHARMACY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2019

5.


Debtors

2019
2018
£
£

Due after more than one year

Prepayments and accrued income
72,600
75,900

72,600
75,900


2019
2018
£
£

Due within one year

Trade debtors
192,517
97,298

Other debtors
34,271
29,322

Prepayments and accrued income
18,112
18,741

244,900
145,361



6.


Cash and cash equivalents

2019
2018
£
£

Cash at bank and in hand
6
232

Less: bank overdrafts
(116,453)
(21,206)

(116,447)
(20,974)


Page 6

 
VICTORIA PHARMACY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2019

7.


Creditors: Amounts falling due within one year

2019
2018
£
£

Bank overdrafts
116,453
21,206

Bank loans
103,903
73,356

Trade creditors
240,181
195,943

Corporation tax
-
2,976

Other taxation and social security
2,035
8,788

Obligations under finance lease and hire purchase contracts
645
2,964

Other creditors
115
74

Accruals and deferred income
3,168
46,773

466,500
352,080


Details of security provided:
Included in creditors are obligations under finance lease and hire purchase contracts of £645 (2018: £3,211) which are secured on the related assets.
Included within creditors are bank loans on which there are fixed and floating charges over the undertaking and all property and assets present and future including goodwill book debts uncalled capital and buildings fixtures fixed plant and machinery.


8.


Creditors: Amounts falling due after more than one year

2019
2018
£
£

Net obligations under finance leases and hire purchase contracts
-
247

-
247



9.


Hire purchase and finance leases


Minimum lease payments under hire purchase fall due as follows:

2019
2018
£
£


Within one year
645
2,964

Between 1-5 years
-
247

645
3,211

Page 7

 
VICTORIA PHARMACY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2019

10.


Related party transactions

During the year the company purchased stock of £166 from Durham Pharmaceuticals Limited, a company controlled by P R W Grundy, a director of M Whitfield Limited (a corporate director).

 
Page 8